Correlation Between MAG SILVER and BioNTech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MAG SILVER and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MAG SILVER and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MAG SILVER and BioNTech SE, you can compare the effects of market volatilities on MAG SILVER and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MAG SILVER with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of MAG SILVER and BioNTech.

Diversification Opportunities for MAG SILVER and BioNTech

-0.42
  Correlation Coefficient

Very good diversification

The 3 months correlation between MAG and BioNTech is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding MAG SILVER and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and MAG SILVER is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MAG SILVER are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of MAG SILVER i.e., MAG SILVER and BioNTech go up and down completely randomly.

Pair Corralation between MAG SILVER and BioNTech

Assuming the 90 days trading horizon MAG SILVER is expected to generate 6.68 times less return on investment than BioNTech. But when comparing it to its historical volatility, MAG SILVER is 1.31 times less risky than BioNTech. It trades about 0.02 of its potential returns per unit of risk. BioNTech SE is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  10,750  in BioNTech SE on October 10, 2024 and sell it today you would earn a total of  1,540  from holding BioNTech SE or generate 14.33% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

MAG SILVER  vs.  BioNTech SE

 Performance 
       Timeline  
MAG SILVER 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in MAG SILVER are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, MAG SILVER is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
BioNTech SE 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in BioNTech SE are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, BioNTech exhibited solid returns over the last few months and may actually be approaching a breakup point.

MAG SILVER and BioNTech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MAG SILVER and BioNTech

The main advantage of trading using opposite MAG SILVER and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MAG SILVER position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.
The idea behind MAG SILVER and BioNTech SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Valuation
Check real value of public entities based on technical and fundamental data
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
CEOs Directory
Screen CEOs from public companies around the world